Duloxetine for the Prevention of Oxaliplatin Induced Peripheral Neuropathy: A Randomized, Placebo-Controlled, Double-blind Clinical Trial

ConclusionAlthough a definite conclusion might be difficult to draw but administering duloxetine for 14  days in each chemotherapy cycle could not decrease the incidence of acute OIPN based on CTCAE grading system.
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research